Rice Derica W 4

What Happened Derica W. Rice, a director of Bristol Myers Squibb Co. (BMY), was granted 638.912 Deferred Share Units on 2026-03-31. The units are recorded at a grant value of $60.65 per unit, totaling $38,750. This transaction is coded as an award/grant (A), not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-03-31; filing date: 2026-04-02 (filing appears timely).
• Instrument: 638.912 Deferred Share Units at $60.65 per unit; total value reported $38,750.
• Shares owned after transaction: not specified in this Form 4 filing.
• Footnote F1: Each Deferred Share Unit converts into one share of common stock upon settlement; units become settleable when the director leaves the board or at a future date previously specified by the reporting person.
• Footnote F2: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non‑Employee Directors.
• Transaction code: A = Award/Grant.

Context Deferred Share Units are a form of deferred compensation for non‑employee directors and convert into actual shares at settlement (often upon departure or a pre‑set date). Such director grants are common and routine compensation, so they don't necessarily indicate the insider's view on the company's near‑term stock performance.